In addition, the c–Raf/MEK/ERK signaling pathway has been known to play a critical role in the development of various cancers, including melanoma, non−melanoma skin cancers, pancreatic cancer, and non−small cell lung cancer [46,47,48]. Here, RAF1 is linked to familial pancreatic carcinoma.